  Succinylcholine (Anectine, Quelicin) section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } th, td { padding: 0px 8px 0px 8px; text-align: left; vertical-align: top; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; } .text-center { text-align: center; }

### Cisatracurium Besylate (Nimbex) Dosing-Peds

<table style="width: inherit;"><tbody><tr><th style="width: 18%;">Age range</th><td><p>1 month -12 years</p><p>Avoid &lt; 1 month of age and low birth-weight infants</p><p>if the formulation contains benzyl alcohol.</p></td></tr><tr><th>Intubating dose</th><td><p>0.15 mg/kg over 5 to 10 seconds</p></td></tr><tr><th>Maintenance</th><td><p>0.01-0.05 mg/kg</p></td></tr><tr><th>Continuous Infusion ICU</th><td><p><b>Infant:</b> 2.8 mcg/kg/min</p><p><b>Child:</b> 3.9 ± 1.4 mcg/kg/min</p><p><em>Literature varies with recommended infusion rates</em></p><p><em>Titrate to maintain 1-2 twitches</em></p></td></tr><tr><th>Infusion Opioids anesthesia</th><td><p>Recommended only for Ages 2 and older</p><p><b>Infant:</b> 1.3-2.5 mcg/kg/min</p><p><b>Child:</b> 1-4 mcg/kg/min or 0.06-0.24 mg/kg/hr</p><p><em>Literature varies with recommended infusion rates</em></p><p><em>Titrate to maintain 1-2 twitches</em></p></td></tr><tr><th>Onset</th><td><p><b>Infant/child (1-23 months):</b> 90 secs</p><p><b>Child: (2-12 years):</b> 90 secs</p></td></tr><tr><th>Duration</th><td><p>20-50 minutes</p></td></tr><tr><th>Distribution time (children)</th><td><p>3.5 minutes</p></td></tr><tr><th>Elimination time children</th><td><p>23 minutes</p></td></tr><tr><th>Contraindications</th><td><p>Hypersensitivity to Cisatracurium</p><p class="text-red">Peds &lt; 1 month of age and low birth-weight infants, because the formulation contains benzyl alcohol</p></td></tr></tbody></table>

Smith’s Anesthesia for Infants and Children, 2022, pp. 268, 270-271,

Peter J. Davis and Frnklin P. Cladis

Cote and Lerman’s: A Practice of Anesthesia for Infants and Children, 5th Ed. 2019, pp 149

Charles Cote, Jarrold Lerman and Brian Anderson

Use of Cisatracurium in the Pediatric Intensive Care Unit

Pediatric Pharmacotherapy, Sept. 2013, vol.19, no. 9

University Virgina Children’s Hospital (accessed 09/2025)

_Marcia L. Buck, Pharm.D., FCCP, FPPAG_